[1]唐神结.耐药结核病防治手册[M].北京:人民卫生出版社,2009:151-152.[2] 唐神结,肖和平.严重耐多药结核病的研究进展[J].中华结核和呼吸杂志,2009,32(5):380-383.[3] Shah NS,Wright A, Bai GH, Barrera L, Boulahbal F, Martín-Casabona N, Drobniewski F, Gilpin C, Havelková M, Lepe R, Lumb R, Metchock B, Portaels F, Rodrigues MF, Rüsch-Gerdes S, Van Deun A, Vincent V, Laserson K, Wells C, Cegielski JP.Worldwide emergence of extensively drug-resistant tuberculosis. Emerging InfectiousDiseases,2007,13(3):380-387.[4] World Health Organization.Global tuberculosis control:epidemiology,strategy, financing:WHO report 2009(WHO/HTM/TB/2009.411).[5] World HealthOrganization. Policy guidance on drug-susceptibility testing(DST) of secondline antituberculosis drugs.Geneva:World HealthOrganization,2008(WHO/HTM/TB/2008.392).[6] 中华医学会.临床诊疗指南(结核病分册)[M].北京:人民卫生出版社,2005.64-86.[7] Jeong YJ, Lee KS.Pulmonary tuberculosis: up-to-date imaging and management[J]. Am J Roentgenol,2008,191(3):834-844.[8] Miller WT,Miller WT Jr.Tuberculosis in the normal host:radiological findings[J].Semin Roentgenol,1993,28:109-118.[9] Kiyan E, Kilicaslan Z, Gurgan M, Tunaci A, Yildiz A.Clinical and radiographic features of pulmonary tuberculosis in non-AIDS immunocompromised patients[J]. Int J Tuberc Lung Dis,2003,7(8):764-770. [10]罗道宝,刘岩,杨芳玲,李程瑜,屈艳红.耐药结核分枝杆菌肺结核的影像分析[J].中国误诊学杂志,2007,7(5):990. |